Highlights from the 2019 ASCO Annual Meeting - Gastrointestinal Cancers
In this episode, we'll listen to Dr. Scott Berry, Dr. Marc Peeters and Dr. Sharlene Gill, discuss the important trials presented at ASCO 2019. 08:20 - Apact Trial 16:35 - Phase 3 Trial of 1st Line Chemo vs Pembrolizumab vs Chemo + Pembrolizumab for Metastatic Gastric CA 24:15 - Phase 3 Trial of 2nd Line Pembrolizumab vs Placebo for HCC 30:26 - ABC-06 35:35 - IDEA Study (High Risk Stage 2 Patients) 46:19 - Foxtrot Trial
